Electroencephalographic Cross-Frequency Coupling as a Sign of Disease Progression in Patients With Mild Cognitive
Christian Sandøe Musaeus1, Malene Schjønning Nielsen2, Jørgen Sandøe Musaeus3
1Department of Neurology, Danish Dementia Research Centre (DDRC), Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Abstract:
Mild cognitive impairment (MCI) refers to mild objective cognitive deficits and is associated with the later development of Alzheimer's disease (AD). However, not all patients with MCI convert to AD. EEG spectral power has shown promise as a marker of progression, but brain oscillations in different frequencies are not isolated entities. Coupling between different frequency bands, so-called cross-frequency coupling (CFC), has been associated with memory function and may further contribute to our understanding of what characterizes patients with MCI who progress to AD. In the current study, we wanted to investigate the changes in gamma/theta CFC in patients with AD and MCI compared to HC and in patients with pMCI compared to patients with sMCI. Furthermore, we wanted to investigate the association with cognitive test scores. EEGs were included at baseline for 15 patients with AD, 25 patients with MCI, and 36 older HC, and the participants were followed for up to 3 years. To investigate CFC, we calculated the modulation index (MI), which has been shown to be less affected by noisy data compared to other techniques. We found that patients with pMCI showed a significantly lower global gamma/theta CFC compared to patients with sMCI. In addition, global gamma/theta CFC was significantly correlated with Addenbrooke's Cognitive Examination (ACE) score (p-value = 0.030, rho = 0.527). Although not significant, patients with AD and MCI showed a lower gamma/theta CFC compared to HC. These findings suggest that gamma/theta CFC is important for proper cognitive functioning and that a decrease in gamma/theta CFC in patients with MCI may be a sign of progression. Gamma/theta CFC may therefore serve as a progression marker in MCI, but larger studies are needed to validate these findings.
Insights
Patients with progressing Mild Cognitive Impairment (MCI) show lower gamma/theta cross-frequency coupling (CFC) compared to stable MCI. This brain oscillation pattern may indicate future Alzheimer's disease development.
Area of Science:
- Neuroscience
- Cognitive Science
- Biomarkers
Background:
- Mild Cognitive Impairment (MCI) is a precursor to Alzheimer's Disease (AD), but not all individuals with MCI progress.
- Brain oscillations and their interactions, specifically cross-frequency coupling (CFC), are implicated in cognitive functions like memory.
- Understanding changes in CFC may differentiate MCI patients who progress to AD from those who remain stable.
Purpose of the Study:
- To investigate alterations in gamma/theta cross-frequency coupling (CFC) in patients with AD and MCI compared to healthy controls (HC).
- To compare gamma/theta CFC between patients with progressing MCI (pMCI) and stable MCI (sMCI).
- To explore the association between gamma/theta CFC and cognitive test scores.
Main Methods:
- Electroencephalography (EEG) data were collected at baseline from 15 AD patients, 25 MCI patients, and 36 HC.
- Participants were followed for up to 3 years.
- Gamma/theta cross-frequency coupling (CFC) was quantified using the modulation index (MI).
Main Results:
- Patients with pMCI exhibited significantly lower global gamma/theta CFC compared to patients with sMCI.
- Global gamma/theta CFC showed a significant positive correlation with the Addenbrooke's Cognitive Examination (ACE) score.
- While not statistically significant, AD and MCI patients displayed reduced gamma/theta CFC relative to HC.
Conclusions:
- A decrease in gamma/theta CFC may serve as a potential progression marker for MCI towards AD.
- Gamma/theta CFC is associated with cognitive performance, suggesting its importance in maintaining cognitive function.
- Larger studies are required to validate gamma/theta CFC as a reliable progression marker in MCI.


